Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How Long Does It Take to Get Givlaari (givosiran) Approved by Blue Cross Blue Shield in California? Complete Timeline and Fast-Track Guide

Answer Box: Fastest Path to Givlaari Approval Getting Givlaari (givosiran) approved by Blue Cross Blue Shield in California typically takes 14 calendar days for standard review or 2 business days for expedited review when urgent medical necessity is documented. Your hepatologist must submit prior authorization through Blue Shield's

How to Get Garadacimab (Andembry) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Garadacimab Covered by BCBS in Washington Garadacimab (Andembry) requires prior authorization from Blue Cross Blue Shield plans in Washington. Submit a formulary exception request with confirmed HAE diagnosis (ICD-10 D84.1), lab results showing low C4 and C1-INH levels, and documentation of prior therapy failures. If denied,

How to Get Taltz (Ixekizumab) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization Guide & Appeal Scripts

Quick Answer: Getting Taltz Covered in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Taltz (ixekizumab), typically including step therapy with at least one TNF inhibitor failure. Most commercial and health exchange plans classify Taltz as non-preferred, while Medicaid managed plans may offer preferred status. The

Trikafta Coverage with Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Trikafta Covered by Blue Cross Blue Shield in New York Blue Cross Blue Shield requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) in New York. Your CF specialist must submit documentation including CFTR genotype results, baseline labs, and clinical justification. If denied, you have 180 days for

Myths vs. Facts: Getting Naglazyme (Galsulfase) Covered by Blue Cross Blue Shield in Washington

Quick Answer: Getting Naglazyme (galsulfase) covered by Blue Cross Blue Shield in Washington requires prior authorization with confirmed MPS VI diagnosis via enzyme assay, genetic testing, and clinical documentation. If denied, you have 180 days to appeal internally, then can request external review through Washington's Insurance Commissioner within

Renewing Orfadin (Nitisinone) Approval with Blue Cross Blue Shield in Illinois: Complete Timeline and Documentation Guide

Answer Box: Renewing Orfadin Coverage in Illinois Blue Cross Blue Shield of Illinois requires annual prior authorization renewal for Orfadin (nitisinone) with updated clinical documentation proving ongoing medical necessity. Submit renewal requests 30-60 days before expiration using the Illinois Uniform Prior Authorization Form through Prime Therapeutics, including current succinylacetone levels

Work With Your Doctor to Get Fintepla (Fenfluramine) Approved by Blue Cross Blue Shield in California: Complete Provider Collaboration Guide

Answer Box: Getting Fintepla Approved in California Fintepla (fenfluramine) requires prior authorization from Blue Cross Blue Shield California, including REMS enrollment documentation and echocardiogram results to confirm eligibility for Dravet or Lennox-Gastaut syndrome. Your doctor must first enroll as a prescriber and enroll you as a patient at FinteplaREMS.com,

How to Get Symdeko/Symkevi Covered by Blue Cross Blue Shield North Carolina: Complete Prior Authorization and Appeals Guide

Quick Answer: Blue Cross Blue Shield of North Carolina covers Symdeko/Symkevi (tezacaftor/ivacaftor) as a Tier 5 specialty medication requiring prior authorization and genetic testing documentation. Submit PA through your CF specialist with CFTR genotype results showing F508del or responsive mutations. If denied, appeal internally within 180 days, then

How to Get Vigabatrin (Sabril) Covered by Blue Cross Blue Shield of Texas: Complete PA Forms, Appeals, and Coding Guide

Answer Box: Getting Vigabatrin Covered in Texas Blue Cross Blue Shield of Texas requires prior authorization for vigabatrin (Sabril) with REMS enrollment and vision testing documentation. File PA using CVS Caremark Form 548-A, include ICD-10 codes (G40.822 for infantile spasms, G40.824 for refractory seizures), and submit baseline vision

Get Zolgensma Covered by Florida Blue Cross Blue Shield: Complete Prior Authorization and Appeals Guide (2025)

Quick Answer: Getting Zolgensma Covered by Florida Blue in 2025 Florida Blue requires prior authorization for Zolgensma with strict criteria: confirmed SMA diagnosis via genetic testing (bi-allelic SMN1 deletion), patient age under 24 months, negative AAV9 antibody testing, and comprehensive medical records. Submit through their PA portal with chart notes